The Patent Finder

Veracyte, Inc.

29 patents currently held · Updated Nov 22, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as Allegro Diagnostics Corp. (to 2016)

Previously recorded as Decipher Biosciences, Inc. (to 2023)

14
Ending by 2030
May 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 7, 2027
    The maintenance fee for Compositions and Methods for Classifying Thyroid Nodule Disease (US 9,074,258) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Compositions and methods for classifying thyroid nodule disease (US 10,422,009) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due Apr 15, 2027
    The maintenance fee for Methods and Compositions for Classification of Samples (US 10,446,272) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
  • 2 fees due Jun 8 to 24, 2027 · next Jun 8
  • 2 fees due Jul 7 to 16, 2027 · next Jul 7
  • 1 fee due Nov 7, 2027
    The maintenance fee for Methods and systems for detecting usual interstitial pneumonia (US 11,976,329) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,865,452Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
In force
 · USPTO record
In forceUSPTO record
US 10,114,924Methods for Processing or Analyzing Sample of Thyroid Tissue
In force
 · High confidence
In forceHigh confidence
US 10,236,078Methods for Processing or Analyzing a Sample of Thyroid Tissue
In force
 · High confidence
In forceHigh confidence
US 10,672,504Algorithms for Disease Diagnostics
In force
 · High confidence
In forceHigh confidence
US 10,731,223Algorithms for Disease Diagnostics
In force
 · High confidence
In forceHigh confidence
US 12,305,238Methods for Treatment of Thyroid Cancer
In force
 · Low confidence
In forceLow confidence
US 9,714,452Compositions and Methods for Classifying Thyroid Nodule Disease
In force
 · High confidence
In forceHigh confidence
US 10,422,009Compositions and methods for classifying thyroid nodule disease
In force
 · USPTO record
In forceUSPTO record
US 9,206,482Systems and Methods for Expression-Based Classification of Thyroid Tissue
In force
 · High confidence
In forceHigh confidence
US 9,617,604Systems and Methods for Expression-Based Classification of Thyroid Tissue
In force
 · High confidence
In forceHigh confidence
10 of 29 patents shown.
Pro members see all 29.
Pro members: see all 29 patents
Also on record, not counted in the 29: 5 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 pending · 21 abandoned · 15 no status recorded

Showing 1 to 10 of 49, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/255,992Systems and Methods for Preprocessing Target Data and Generating Predictions Using a Machine Learning ModelJun 30, 2025Pending
19/197,756Methods for Classification of Tissue Samples as Positive or Negative for CancerMay 2, 2025Pending
19/195,101Apr 30, 2025No status recorded
18/824,789Genetic Signatures to Predict Prostate Cancer Metastasis and Identify Tumor AggressivenessSep 4, 2024Pending
18/794,160Methods and Compositions for Classification of SamplesAug 5, 2024Pending
18/582,235Use of a Genetic Signature Diagnostically to Evaluate Treatment Strategies for Prostate CancerFeb 20, 2024Pending
18/411,722Subtyping Prostate Cancer to Predict Response to Hormone TherapyJan 12, 2024Pending
18/477,331Methods and Systems to Identify a Lung DisorderSep 28, 2023Pending
18/328,541Clinical Classifiers and Genomic Classifiers and Uses ThereofJun 2, 2023Pending
18/864,879May 11, 2023No status recorded
10 of 49 applications shown.
Pro members see all 49 published applications.
Pro members: see all 49 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited